JZP-430 |
| Katalog-Nr.GC34640 |
JZP-430 ist ein potenter, hochselektiver, irreversibler Inhibitor der α/β-Hydrolase-DomÄne 6 (ABHD6) mit einem IC50 von 44 nM, weist eine ~230-fache SelektivitÄt gegenÜber FettsÄureamidhydrolase (FAAH) und lysosomaler SÄurelipase (LAL) auf ).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1672691-74-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL)[1]. IC50: 44 nM (ABHD6, human)[1]
[1]. Patel JZ, et al. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. ChemMedChem. 2015 Feb;10(2):253-65.
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *